Skip to main content

Eli Lilly and Company balance sheet

  • LLY · NYSE
  • Pharmaceuticals
  • S&P 500
$1443.50+1.14%Close 13 Nov 2026 · Market value $1.36T

At the end of fiscal 2025 (the year to 31 Dec 2025), Eli Lilly and Company reported total assets of $112.5B, $7.27B in cash and equivalents, $43.87B of total debt; shareholders' equity was $26.54B.

From Eli Lilly and Company's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Eli Lilly and Company balance sheet, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$3.22B$5.50B$4.46B$5.99B$5.92B$4.02B$3.83B$3.87B$3.67B$4.58B$6.54B$7.32B$2.34B$3.66B$3.82B$2.07B$2.82B$3.27B$7.27B
Short-term investments—$429.4M$34.70M$733.8M$974.6M$1.67B$1.57B$955.4M$785.4M$1.46B$1.50B$88.20M$101.0M$24.20M$90.10M$144.8M$109.1M$154.8M—
Cash and short-term investments$3.22B$5.93B$4.50B$6.73B$6.90B$5.68B$5.40B$4.83B$4.45B$6.04B$8.03B$7.41B$2.44B$3.68B$3.91B$2.21B$2.93B$3.42B$7.27B
Accounts receivable—$2.78B$3.34B$3.49B$3.60B$3.34B$3.43B$3.23B$3.51B$4.03B$4.55B$4.59B$4.55B$5.88B$6.67B$6.90B$9.09B$11.01B$17.76B
Inventory—$2.49B$2.85B$2.52B$2.30B$2.64B$2.93B$2.74B$3.45B$3.56B$4.46B$3.10B$3.19B$3.98B$3.89B$4.31B$5.77B$7.59B$13.74B
Current assets—$12.45B$12.49B$14.84B$14.25B$13.04B$13.10B$11.93B$12.57B$15.10B$19.20B$20.55B$13.71B$17.46B$18.45B$18.03B$25.73B$32.74B$55.63B
Property, plant and equipment—$8.63B$8.20B$7.94B$7.76B$7.76B$7.98B$7.96B$8.05B$8.25B$8.83B$8.00B$7.87B$8.68B$8.99B$10.14B$12.91B$17.10B$24.68B
Goodwill——$1.18B$1.42B$1.43B$1.50B$1.52B$1.76B$4.04B$3.97B$4.37B$1.37B$3.68B$3.77B$3.89B$4.07B$4.94B$5.77B$5.90B
Acquired intangibles—————$3.19B$2.81B$2.88B$5.03B$4.36B$4.03B$1.07B$6.62B$7.45B$7.69B$7.21B$6.91B$6.17B$6.52B
Long-term investments—$1.54B$1.16B$1.78B$4.03B$6.31B$7.62B$4.57B$3.65B$5.21B$5.68B$2.01B$1.96B$2.97B$3.21B$2.90B$3.05B$3.22B$2.80B
Total assets—$29.21B$27.46B$31.00B$33.66B$34.40B$35.25B$36.31B$35.57B$38.81B$44.98B$43.91B$39.29B$46.63B$48.81B$49.49B$64.01B$78.72B$112.5B
Accounts payable—$885.8M$968.1M$1.07B$1.13B$1.19B$1.12B$1.13B$1.34B$1.35B$1.41B$1.21B$1.41B$1.61B$1.67B$1.93B$2.60B$3.23B$5.38B
Short-term borrowings—$5.85B$27.40M$156.0M$1.52B$11.90M$1.01B$2.68B$0.00$1.30B$2.70B$498.9M$1.49B$0.00$0.00$1.50B$6.19B$4.34B$0.00
Long-term debt · current portion——−$20.30M$18.20M$1.52B$11.90M$1.01B$2.69B$6.10M$1.94B$3.71B$1.10B$1.50B$8.70M$1.54B$1.50B$6.90B$5.12B$1.64B
Current liabilities—$13.11B$6.57B$6.93B$8.93B$8.39B$8.92B$9.74B$8.23B$10.99B$14.54B$11.89B$11.78B$12.48B$15.05B$17.14B$27.29B$28.38B$35.23B
Long-term debt · non-current—$4.62B$6.63B$6.77B$5.46B$5.52B$4.20B$5.33B$7.97B$8.37B$9.94B$9.20B$13.82B$16.59B$15.35B$14.74B$18.32B$28.53B$40.87B
Operating lease liability————————————$608.4M$663.7M$685.7M$728.2M$1.11B$1.15B—
Total liabilities—$22.47B$17.93B$18.60B$20.13B$19.63B$17.61B$20.92B$20.98B$24.73B$33.31B$33.00B$36.59B$40.81B$39.65B$38.71B$53.14B$64.36B$85.94B
Retained earnings—$7.65B$9.83B$12.73B$14.90B$16.09B$16.99B$16.48B$16.01B$16.05B$13.89B$11.40B$4.92B$7.83B$8.96B$10.04B$10.31B$13.54B$24.47B
Minority interest—$2.40M$1.60M−$7.50M−$6.10M$8.70M$9.30M$14.90M$19.00M$72.80M$75.70M$1.08B$92.20M$183.6M$175.6M$125.6M$91.80M$79.50M—
Shareholders' equity—$6.74B$9.53B$12.41B$13.54B$14.77B$17.63B$15.37B$14.57B$14.01B$11.59B$9.83B$2.61B$5.64B$8.98B$10.65B$10.77B$14.27B$26.54B
Total liabilities and equity—$29.21B$27.46B$31.00B$33.66B$34.40B$35.25B$36.31B$35.57B$38.81B$44.98B$43.91B$39.29B$46.63B$48.81B$49.49B$64.01B$78.72B$112.5B
Total debt—$10.46B$6.64B$6.94B$8.50B$5.54B$5.21B$8.02B$7.98B$10.31B$13.65B$10.30B$15.93B$17.26B$17.57B$16.97B$26.33B$34.79B$43.87B
Net debt—$4.54B$2.14B$217.7M$1.61B−$141.1M−$184.4M$3.19B$3.53B$4.27B$5.61B$2.89B$13.49B$13.58B$13.66B$14.76B$23.41B$31.37B$36.60B
Net working capital—−$6.15B$1.46B$1.92B−$605.2M$630.4M$357.9M−$1.68B$677.6M−$467.3M−$1.87B$1.34B−$403.1M$1.32B−$418.8M−$1.17B−$4.38B$1.10B$13.13B
Shares outstanding · period end——1.2B1.2B1.2B1.1B1.1B1.1B1.1B1.1B1.1B1.0B956M958M952M950M950M948M943M

Quarterly

Eli Lilly and Company balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$2.82B$2.46B$3.22B$3.37B$3.27B$3.09B$3.38B$9.79B$7.27B$5.28B$8.95B$4.88B
Short-term investments$109.1M$126.1M$140.4M$149.4M$154.8M$127.4M$170.1M$121.6M————
Cash and short-term investments$2.93B$2.59B$3.36B$3.52B$3.42B$3.22B$3.55B$9.91B$7.27B$5.28B$8.95B$4.88B
Accounts receivable$9.09B$7.89B$11.03B$10.29B$11.01B$12.04B$14.17B$16.11B$17.76B$18.43B$20.08B$22.09B
Inventory$5.77B$6.10B$6.48B$7.46B$7.59B$9.31B$11.01B$12.18B$13.74B$14.53B$16.79B$18.19B
Current assets$25.73B$25.19B$30.20B$31.42B$32.74B$41.26B$49.85B$62.07B$55.63B$54.84B$64.67B$65.26B
Property, plant and equipment$12.91B$13.62B$14.83B$16.17B$17.10B$18.47B$20.53B$22.32B$24.68B$26.54B$29.29B$32.19B
Goodwill$4.94B$4.94B$5.77B$5.77B$5.77B$5.77B$5.77B$5.90B$5.90B$6.13B$8.85B$9.87B
Acquired intangibles$6.91B$6.76B$6.64B$6.54B$6.17B$6.01B$5.91B$6.45B$6.52B$7.37B$18.11B$18.08B
Long-term investments$3.05B$3.09B$2.88B$3.20B$3.22B$3.22B$3.21B$2.81B$2.80B$3.12B$3.86B$4.01B
Total assets$64.01B$63.94B$71.87B$75.61B$78.72B$89.39B$100.9B$114.9B$112.5B$116.6B$142.3B$148.1B
Accounts payable$2.60B$2.47B$2.92B$2.89B$3.23B$3.44B$4.08B$4.26B$5.38B$5.03B$6.11B$5.79B
Short-term borrowings$6.19B———$4.34B———$0.00———
Long-term debt · current portion$6.90B$1.65B$5.16B$2.07B$5.12B$4.02B$5.72B$1.63B$1.64B$4.00B$7.05B$2.52B
Current liabilities$27.29B$18.60B$27.12B$24.67B$28.38B$30.07B$39.02B$40.14B$35.23B$36.63B$47.74B$47.00B
Long-term debt · non-current$18.32B$24.56B$23.73B$29.05B$28.53B$34.50B$34.18B$40.87B$40.87B$39.37B$47.86B$46.99B
Operating lease liability$1.11B———$1.15B———————
Total liabilities$53.14B$51.05B$58.24B$61.29B$64.36B$73.54B$82.57B$91.08B$85.94B$85.38B$108.4B$107.8B
Retained earnings$10.31B$12.55B$13.18B$13.63B$13.54B$15.10B$17.38B$22.25B$24.47B$29.51B$31.89B$37.97B
Minority interest$91.80M$85.20M$73.50M$80.70M$79.50M$82.00M$76.20M$57.50M————
Shareholders' equity$10.77B$12.81B$13.56B$14.24B$14.27B$15.76B$18.27B$23.79B$26.54B$31.20B$33.88B$40.27B
Total liabilities and equity$64.01B$63.94B$71.87B$75.61B$78.72B$89.39B$100.9B$114.9B$112.5B$116.6B$142.3B$148.1B
Total debt$26.33B$26.21B$28.89B$31.12B$34.79B$38.52B$39.90B$42.51B$43.87B$43.37B$54.91B$49.50B
Net debt$23.41B$23.63B$25.53B$27.60B$31.37B$35.30B$36.36B$32.59B$36.60B$38.09B$45.96B$44.62B
Net working capital−$4.38B$4.13B−$140.5M$3.37B$1.10B$8.10B$7.46B$12.14B$13.13B$12.92B$7.98B$13.38B
Shares outstanding · period end950M950M950M949M948M948M946M945M943M942M941M941M

The main figures as JSON and plain text. See data and methodology.

LLY in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.